The United Laboratories International Holdings Limited
The United Laboratories International Holdings Limited (HKSE: 3933) is trading at HK$7.64, about ₹93 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, down 0.84% today. Indian residents can buy The United Laboratories International from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$7.49
Today's high
HK$7.71
52 week low
HK$7.49
52 week high
HK$15.48
3933 opened at HK$7.68, closed previously at HK$7.71, and has traded between HK$7.49 and HK$15.48 over the past 52 weeks.
About
The United Laboratories International Holdings Limited functions as an investment holding company with a primary focus on the pharmaceutical sector. Its multifaceted operations cover the entire lifecycle of drug development and commercialization, from pioneering research and development to manufacturing, distribution, and sales. The company structures its diverse business into three core divisions: Bulk Medicine, Intermediate Products, and Finished Goods. Its broad product portfolio features a variety of medications, such as oral antibiotics, injectable antimicrobials, cold and cough remedies, ophthalmic solutions, antiviral and anti-hepatitis B drugs, diabetes treatments, topical dermatological preparations, cardiovascular and neurological pharmaceuticals, vitamins, and empty gelatin capsules, alongside active pharmaceutical ingredients (APIs) and other intermediary compounds. Furthermore, the company manufactures and markets soft capsule shells, holds trademarks, engages in pharmaceutical trading, and provides management services. Founded in 1990 and headquartered in Yuen Long, Hong Kong, the firm maintains a significant global reach, conducting business throughout the People's Republic of China, Europe, India, the Middle East, South America, other Asian territories, and internationally.
Key statistics
Avg. volume
7.64M
Market cap
HK$15.05B
P/E Ratio
23.47
Price-to-sales ratio
1.08
Enterprise value
CN¥7.08B
Free cash flow yield
4.82%
Debt-to-equity ratio
0.35
Return on equity
3.12%
ROIC
2.11%
Beta
0.29
Dividend yield
3.91%
Last dividend
HK$0.30
Financial overview
Revenue
CN¥13.21B
Earnings per share
CN¥1.11
Free cash flow
CN¥855.45M
Net profit margin
4.55%
Gross margin
31.28%
EBITDA
CN¥2.83B
Revenue growth
-3.99%
Similar securities
This is not an investment recommendation
How to buy The United Laboratories International from India
Indian residents can buy The United Laboratories International shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for The United Laboratories International and place an order
Find The United Laboratories International by name or by its ticker, 3933, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. The United Laboratories International trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your The United Laboratories International position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in The United Laboratories International from India
Trading and taxes when buying The United Laboratories International from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. The United Laboratories International’s current yield is 3.91%.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy The United Laboratories International stock?
Yes. The United Laboratories International (3933) has been listed on the Hong Kong Stock Exchange since 2007, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one The United Laboratories International share cost in rupees?
One The United Laboratories International share is HK$7.64 — about ₹93 at an HKD/INR rate of 12.23 on 26 Sep 2026. Both the The United Laboratories International price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying The United Laboratories International from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of The United Laboratories International?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on The United Laboratories International shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the The United Laboratories International price. Paasa issues a capital-gains statement for your return.
Does The United Laboratories International pay a dividend, and how is it taxed in India?
Yes. The United Laboratories International pays a dividend and the current yield is 3.91%; the last declared dividend was HK$0.30 per share, about ₹3.66. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade The United Laboratories International from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on The United Laboratories International shares held from India?
Hong Kong has no estate duty.
Do I have to declare The United Laboratories International shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your The United Laboratories International holding, its cost and its closing value.
How do I sell The United Laboratories International and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.